Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Rachel Cook
The Combination of NPM1, DNMT3A and IDH1/2 Mutations Leads to Inferior Overall Survival in AML
American Journal of Hematology
Hematology
Feasibility and Cost Analysis of Day 4 Granulocyte Colony-Stimulating Factor Mobilized Peripheral Blood Progenitor Cell Collection From HLA-Matched Sibling Donors
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Related publications
A Distinct Immunophenotype Identifies a Subset of NPM1 -Mutated AML With TET2 or IDH1/2 Mutations and Improved Outcome
American Journal of Hematology
Hematology
IDH1/2 Mutations Predict Shorter Survival in Chondrosarcoma
Journal of Cancer
Oncology
Dominating the Negative: How DNMT3A Mutations Contribute to AML Pathogenesis
Cell Stem Cell
Molecular Medicine
Genetics
Cell Biology
Biological and Clinical Influences of NPM1 in Acute Myeloid Leukemia Patients With DNMT3A Mutations
Cancer Management and Research
Oncology
Impact of Chemotherapy Delay on Overall Survival for AML With I DH1/2 Mutations: A Study in Adult Chinese Patients
Blood
Biochemistry
Immunology
Cell Biology
Hematology
SRSF2 Mutations in Primary Myelofibrosis: Significant Clustering With IDH Mutations and Independent Association With Inferior Overall and Leukemia-Free Survival
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Mutations of the Epigenetics-Modifying Gene (DNMT3a, TET2, IDH1/2) at Diagnosis May Induce FLT3-ITD at Relapse in De Novo Acute Myeloid Leukemia
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Cancer-Associated IDH1 Mutations Produce 2-Hydroxyglutarate
Nature
Multidisciplinary
Prognostic Relevance of DNMT3A R882 Mutations in AML Patients Undergoing Non-Myeloablative Conditioning Hematopoietic Stem Cell Transplantation
Bone Marrow Transplantation
Transplantation
Hematology
